Sr ophthalmologist Dr P Namperumalsamy no more
He is survived by his wife Dr G Natchiar, director-emeritus of the hospital, and sons Venkatesh Prajna and Vishnu Prasad.
"My father was thorough professional and a perfectionist, be it at work or home. He performed his duties diligently as a father, as a grandfather, and a great grandfather as well,'' Prajna told TOI. "The way he challenged himself constantly and aspired for global standards despite coming from a humble background is a rare feat," he said.
Born on July 9, 1940 in Ambasamudram village in Theni district, Namperumalsamy did his MBBS at Madurai Medical College. His classmate, Dr Annamalaisamy, 86, a cardiologist, recalls that Dr Nam, as he is fondly referred to, entered the college as a timid boy but grew soon to be the smartest. "I met him only two months ago. He never forgot his roots. Even now, after retiring, he has taken an interest in agriculture," he said.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around
Blinkist: Warren Buffett's Reading List
Undo
Namperumalsamy started his career at Government Rajaji Hospital and established India's first Low Vision Aid Clinic in 1967. After training in the US, he started the Vitreous Surgery Centre at GRH, a first of its kind in India, and then Retina Vitreous Clinic at Aravind Eye Hospital in 1979.
Dr Sridhar, state president elect, IMA, Tamil Nadu, says Namperumalsamy was the perfect definition of a gentleman. Under his stewardship, Aravind became a global model for efficient, high-volume, high quality eye care, winning the Conrad N.
Hilton Humanitarian Prize in 2010. TIME magazine recognized him among its 100 most influential people in 2010 for transforming cataract surgery into a rapid, assembly-line operation.
He was also a recipient of Padma Shri.
Several political leaders including chief minister M K Stalin condoled his death. "He gave vision to lakhs of people,'' Stalin said. Dr Namperumal's mortal remains were kept at their house in Anna Nagar in Madurai on Thursday, and will be cremated in his native village on Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!
For many living with type 2 diabetes, managing blood sugar is a daily reality. Often, medications come as a lifeline, and among them, sulfonylureas like glipizide are popular choices, especially in the US. They've been around for decades, are affordable, and have shown effective results in keeping glucose in check. But now, a new study has cast a shadow over this commonly used medicine. Researchers have discovered a possible link between glipizide and increased heart-related risks. Here's what the study found, what it truly means, and why this matters to families where diabetes is part of everyday conversations. Glipizide: Familiar, trusted, But now under scrutiny Glipizide belongs to a group of drugs called sulfonylureas. For decades, these medications have been trusted for lowering blood sugar in people with type 2 diabetes, often when metformin alone isn't enough. What made glipizide popular was its affordability and long-standing availability. But popularity doesn't always mean perfection. The latest study signals a possible red flag. Involving nearly 48,000 individuals, this research found that those taking glipizide had a higher risk of heart attacks, strokes, heart failure hospitalisations, and even cardiovascular-related deaths than those taking a newer class of drugs called DPP-4 inhibitors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo The numbers that raised eyebrows The research compared glipizide with other sulfonylureas like glimepiride and glyburide, along with DPP-4 inhibitors. Here's what stood out: Over a 5-year period, the risk of major heart events was 9.1% in those taking glipizide, while for those on DPP-4 inhibitors, it was 8.1%. The risk ratio for glipizide users was 1.13, indicating a 13% higher risk of cardiovascular events compared to DPP-4 inhibitor users. The risk was also slightly higher with glimepiride (8.6%) and glyburide (8.4%), but not statistically significant. What makes this important is that most participants were on their second diabetes medication after metformin, a common scenario in diabetes care. And they weren't at extremely high cardiac risk to begin with, just moderate, everyday individuals managing a chronic condition. Not just about the numbers, but about what they mean It's easy to be alarmed by statistics. But what do these numbers truly tell us? Firstly, the study doesn't claim that glipizide causes heart problems directly. What it suggests is a possible association, a pattern that raises concerns, especially in people already facing moderate cardiovascular risk. The heart, after all, is already under pressure in type 2 diabetes. When a drug meant to help with sugar control potentially adds to that risk, even slightly, it becomes a serious discussion for healthcare providers. Why affordability might come at a cost Sulfonylureas like glipizide are often the go-to option in low- and middle-income settings because they're inexpensive. DPP-4 inhibitors, on the other hand, are costlier but have a more favourable cardiovascular safety profile. This raises a deeper, more sensitive question: should treatment decisions depend on cost or safety? The answer isn't straightforward. But studies like this push for better informed decisions, where doctors weigh more than just sugar levels, they also look at heart health, overall risk, and long-term quality of life. What this means for families dealing with diabetes This isn't about pushing panic buttons. Glipizide is still an approved and effective drug. But the study offers important insights for personalised diabetes management. It's a reminder that medications work differently for different people, and what works well for one might not be ideal for another, especially when silent risks like cardiovascular strain are involved. It's also a cue to revisit older medications with a fresh lens, especially when newer, safer options are available. The story here isn't about fear, but about awareness and agency. (Inputs from agencies)
Time of India
an hour ago
- Time of India
What Is dry eye disease? Symptoms, causes & how to treat it
Feeling constant eye irritation, burning, or blurred vision after long hours on your phone or laptop? You might be experiencing dry eye disease, a fast-growing modern condition linked to excessive screen time, pollution, and even air conditioning. Once considered a minor inconvenience, it's now recognised as a chronic issue that can affect daily productivity and long-term eye health. Urban lifestyles, digital overload, and poor blinking habits are all culprits. But the good news? Science-backed solutions exist. In this article, we break down what dry eye disease really is, why it's becoming so common, and how to treat and prevent it effectively. What is dry eye disease? Dry eye disease occurs when your eyes either don't produce enough tears or the tears evaporate too quickly. This leads to symptoms like dryness, irritation, a gritty sensation, or even blurred vision. But it's more than just lack of moisture. According to the TFOS DEWS II Report (2017) , dry eye is a complex medical condition involving an unstable tear film, ocular surface inflammation, and in some cases, nerve dysfunction. These factors disrupt normal tear production and eye lubrication, making the condition chronic and often progressive if left untreated. Why is dry eye disease becoming so common? In today's digital-first, urban lifestyle, dry eye disease is rapidly becoming one of the most widespread eye conditions worldwide. But why are more people, especially young adults and even children, experiencing dry, irritated eyes? Here are the top scientifically proven reasons: Too much screen time Staring at phones, laptops, and TVs for long periods significantly reduces your blink rate, causing your tears to evaporate more quickly. This leads to unstable tear film and increased eye dryness. A study by Moon et al . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Prettiest Icons In The History The Noodle Box Undo (2023) revealed that even school children who use digital devices frequently are showing early signs of dry eye disease, pointing to how screen overuse is affecting eye health from a young age. Pollution in the air Airborne pollutants especially PM₂.₅, ozone (O₃), and sulfur dioxide (SO₂) can damage the ocular surface, destabilise your tear film, and trigger chronic inflammation. A large multicenter study by Ran Hao et al. (Frontiers in Medicine, 2022) demonstrated that exposure to these air pollutants was strongly associated with meibomian gland dysfunction, elevated tear cytokine levels, and worsening dry eye symptoms in urban patients. Meibomian gland dysfunction (MGD) Your eyelids contain meibomian glands that secrete oils essential for preventing your tears from evaporating too fast. When these glands become clogged or inflamed, they can no longer protect the tear film effectively, causing evaporative dry eye the most common subtype of dry eye disease today. Other factors Aging and hormonal changes (especially in women) Medical conditions like diabetes and autoimmune diseases Medications like antidepressants, antihistamines, acne pills What are the symptoms of dry eye disease? Not sure if you have it? Watch out for these common symptoms: Burning or stinging in the eyes Redness or irritation Blurry or fluctuating vision Eyes that water too much (sounds odd but it's a response to dryness!) Eye fatigue, especially after using screens These symptoms can affect your focus, work, and even mood over time. How to treat dry eye disease The good news? You can manage dry eye disease with a mix of home care and medical treatments. Here's what works: Artificial tears Over-the-counter artificial tears are often the first line of treatment for dry eye disease. They help replenish moisture on the surface of the eye and relieve symptoms like burning, stinging, and grittiness. For long-term use, it's best to choose preservative-free variants, as preservatives in some eye drops can cause irritation when used too often. These drops can be used several times a day and are especially helpful after prolonged screen time, exposure to wind, or air-conditioned environments. Warm compresses Applying a warm compress over closed eyelids helps to melt the thickened oil in the Meibomian glands, which are responsible for producing the oily layer of your tear film. When these glands get clogged, it leads to quicker evaporation of tears. Use a clean, warm towel or a microwavable eye mask for 5–10 minutes daily. This not only promotes better oil flow but also soothes inflammation and improves overall comfort, especially for those with Meibomian Gland Dysfunction (MGD). Lid hygiene Proper eyelid hygiene is crucial for managing dry eye, especially if you have blepharitis or oil gland issues. Cleaning your eyelids daily helps remove debris, dead skin, and bacteria that can cause inflammation. Use a doctor-recommended lid scrub, diluted baby shampoo, or pre-moistened sterile wipes. Gently clean the base of your eyelashes with a cotton pad or swab. Consistent lid hygiene reduces flare-ups, stabilises the tear film, and improves overall eye comfort. Omega-3 fatty acids Multiple studies have shown that omega-3 supplements, especially those containing EPA and DHA can significantly improve dry eye symptoms by enhancing the quality of oil in your tears. These healthy fats reduce inflammation and support Meibomian gland function. Sources include fish oil capsules, flaxseed oil, chia seeds, and walnuts. Talk to your doctor about dosage, as high-quality supplements may be more effective. They're not a quick fix, but over time, they can be a game-changer for dry eye relief. Prescription eye drops For moderate to severe dry eye cases, your doctor may prescribe medicated eye drops like cyclosporine (Restasis) or lifitegrast (Xiidra). These work by targeting the inflammation in the tear glands and improving natural tear production. Unlike artificial tears, these drops take a few weeks to show results but address the root cause of chronic dry eye. They're especially effective in autoimmune-related cases or when standard over-the-counter drops are not enough. Environmental changes Use a humidifier Avoid dry air or direct AC Follow the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds Dry eye disease is more than just an uncomfortable feeling, it's a real medical condition made worse by modern habits and pollution. The good news? With science-backed treatments and small lifestyle changes, you can get long-term relief and protect your eye health. Don't ignore the signs your eyes are trying to tell you something! Also read| 7,000 steps a day can reduce the risk of diseases like cancer, dementia, and heart problems
Time of India
2 hours ago
- Time of India
Low insurance costs, affordable treatment and medicines drawing NRIs to India
While treatment costs in India are low, so are the medical insurance premiums. (AI image) New Delhi: Low medical insurance premiums, affordable treatment costs and high quality healthcare facilities at private hospitals are making NRIs turn to India for medical treatment, according to a report by Policybazaar. The insurance aggregator noted that the share of NRI buyers of health insurance grew 150% in 2024-25 as compared to the previous year. One of India's most compelling advantages is the dramatic cost difference for medical procedures. Healthcare costs in India are very low compared to what one pays in the US and other developed countries. Patients can save 60-90% on treatments in India. To give you a perspective, here's a comparison of the costs of some surgical procedures in the two countries. Figures are indicative and actual costs may vary depending on the hospital chosen and the location. Treatment Cost in the US Cost in India Heart bypass surgery Rs 60 lakh to Rs 1.3 crore Rs 4.5 lakh to Rs 8 lakh Knee replacement Rs 25 lakh to Rs 45 lakh Rs 3.5 lakh to Rs 5 lakh Liver transplant Rs 2.5 crore to Rs 4 crore Rs 21 lakh to Rs 30 lakh Kidney transplant Rs 1.7 crore to Rs 2.6 crore Rs 6 lakh to Rs 10 lakh *US figures converted to rupees at Rs 86.5 per dollar. Source: Policybazaar While treatment costs in India are low, so are the medical insurance premiums compared to what one pays in the US and other countries. The average annual health insurance premium per person in India is $120-300 (Rs 10,000-26,000), which is significantly lower than $8,000 (Rs 6.9 lakh) payable in the US or $4,000-5,000 (Rs 3.4-4.3 lakh) charged in GCC countries. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Walmart Cameras Captured These Hilarious 20 Photos Undo This has led many NRIS to purchase health cover from insurance companies in India. Policybazaar has also noted a surge in online queries from NRIs expressing interest to buy health insurance in India. According to Google Trends and industry search data, queries like 'Best health insurance plans for parents in India' consistently ranks among the top 5 NRI-related insurance searches from the UAE, UK, and US markets. What's more, even medicines in India are significantly cheaper. For example, a vial of insulin costs Rs 85-400 in India versus Rs 8,600-25,000 in the US. The cost of medicines can add up to a huge amount, but insurance helps cover these at low costs. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
